These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975 [TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Renaud S; Gregor M; Fuhr P; Lorenz D; Deuschl G; Gratwohl A; Steck AJ Muscle Nerve; 2003 May; 27(5):611-5. PubMed ID: 12707982 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies. Vallat JM; Magy L; Ciron J; Corcia P; Le Masson G; Mathis S Expert Rev Neurother; 2016 Sep; 16(9):1111-9. PubMed ID: 27267749 [TBL] [Abstract][Full Text] [Related]
12. Anti-MAG IgM: differences in antibody tests and correlation with clinical findings. Matà S; Ambrosini S; Saccomanno D; Biagioli T; Carpo M; Amantini A; Giannini F; Barilaro A; Toscani L; Del Mastio M; Comi GP; Sorbi S Neurol Sci; 2020 Feb; 41(2):365-372. PubMed ID: 31654362 [TBL] [Abstract][Full Text] [Related]
13. Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy. Baron M; Lozeron P; Harel S; Bengoufa D; Vignon M; Asli B; Malphettes M; Parquet N; Brignier A; Fermand JP; Kubis N; Arnulf B J Neurol; 2017 Jun; 264(6):1132-1135. PubMed ID: 28484839 [TBL] [Abstract][Full Text] [Related]
14. Severe cranial nerve involvement in a patient with monoclonal anti-MAG/SGPG IgM antibody and localized hard palate amyloidosis. Yoshida T; Yazaki M; Gono T; Tazawa K; Morita H; Matsuda M; Funakoshi K; Yuki N; Ikeda S J Neurol Sci; 2006 May; 244(1-2):167-71. PubMed ID: 16546215 [TBL] [Abstract][Full Text] [Related]
15. Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. Andersson M; Yu M; Söderström M; Weerth S; Baig S; Solders G; Link H Eur J Neurol; 2002 May; 9(3):243-51. PubMed ID: 11985632 [TBL] [Abstract][Full Text] [Related]
16. Neuropathy with predominant small fiber involvement associated with abnormal anti-MAG titer. Luigetti M; Madia F; Conte A; Tonali P; Sabatelli M Intern Med; 2010; 49(23):2627-9. PubMed ID: 21139305 [TBL] [Abstract][Full Text] [Related]
17. High-dose rituximab and anti-MAG-associated polyneuropathy. Renaud S; Fuhr P; Gregor M; Schweikert K; Lorenz D; Daniels C; Deuschl G; Gratwohl A; Steck AJ Neurology; 2006 Mar; 66(5):742-4. PubMed ID: 16534115 [TBL] [Abstract][Full Text] [Related]
18. Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies. Delmont E; Jeandel PY; Benaïm C; Rosenthal E; Fuzibet JG; Desnuelle C J Neurol; 2011 Sep; 258(9):1717-9. PubMed ID: 21437663 [No Abstract] [Full Text] [Related]
20. NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy. Benedetti L; Facco M; Franciotta D; Dalla Torre C; Campagnolo M; Lucchetta M; Boscaro E; Ermani M; Del Sette M; Berno T; Candiotto L; Zambello R; Briani C J Neurol Sci; 2013 Aug; 331(1-2):86-9. PubMed ID: 23764364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]